KDM7A and fatty liver disease: Accordingly, we hypothesized that KDM7A epigenetically upregulates DGAT2 expression by erasing the transcriptionally repressive histone marks H3K9me2 and H3K27me2 on the promoter of DGAT2, eventually leading to hepatic steatosis through increasing TG synthesis.